Pouyan Ebrahimi on Maternal Stroke: 270 Million Births, One Alarming Risk
Pouyan Ebrahimi, Medical Doctor and researcher at Babol University of Medical Sciences, shared on LinkedIn:
”270 Million Births, One Alarming Risk: Maternal Stroke
I am pleased to share our latest publication in BMC Pregnancy and Childbirth (Global incidence and risk factors of pregnancy-related stroke: a systematic review and meta-analysis of over 270 million women)
This study provides critical insights into the epidemiology and risk factors of maternal stroke.
Although my current research focus has shifted toward oncology, with the long-term goal of contributing to cancer treatment, there are moments when certain clinical questions still compel my curiosity.
One such question was how a condition as severe as stroke can affect nearly one in three pregnant women.
Our findings reveal that factors such as migraine, dyslipidemia, alcohol use, tobacco smoking, sickle cell disorders, coagulopathy, cardiovascular diseases, preeclampsia/eclampsia/gestational hypertension, and postpartum hemorrhage are significantly associated with increased stroke risk during pregnancy.
Sometimes, we tend to overlook the importance of certain conditions until their impact becomes undeniable.
I hope this study helps raise awareness about maternal stroke and inspires efforts to mitigate its preventable risk factors.
A special thanks to Springer and the dedicated reviewers for their valuable feedback and efforts in improving the quality of this work.”
Read the full article here.
Article: Global incidence and risk factors of pregnancy-related stroke: a systematic review and meta-analysis of over 270 million women
Authors: Malihe Nourollahpour Shiadeh, Kimia Pakdaman, Amin Esmaeilnia Shirvani, Zeinab Hashemi, Pouyan Ebrahimi
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 11, 2026, 16:46Moaz Abouelmagd: Key Findings from a Large Network Meta-Analysis of IV Thrombolytics in Acute Ischemic Stroke
-
Jun 11, 2026, 16:37Wolfgang Miesbach: From Failed Intravitreal Trials to Real Benefit – Subretinal AAV8 Gene Therapy in Pediatric X-Linked Retinoschisis
-
Jun 11, 2026, 16:34Joao Mariano Pego: Advancing Coagulation Diagnostics Through Standardized Thrombin Generation
-
Jun 11, 2026, 16:33Ifeanyichukwu Ifechidere: Nobody Talks About Thrombosis in Sickle Cell Disease
-
Jun 11, 2026, 16:31Karim Mahawish: Ischaemic Stroke Despite Anticoagulation in Atrial Fibrillation
-
Jun 11, 2026, 16:29Salim Virani: The 2026 ACC/AHA Multisociety Dyslipidemia Guideline Promotes Early Prevention
-
Jun 11, 2026, 16:25Toyosi Onwuemene: What Clinicians Reveal About Bleeding and Clotting Care
-
Jun 11, 2026, 16:20Tejas Ahire: Rh Incompatibility – A Small Blood Group Difference with Big Clinical Impact
-
Jun 11, 2026, 16:19Jack Shuang Hou: Bayer Advances Asundexian as EMA Reviews New Option for Preventing Recurrent Ischemic Stroke